Analysis of best response
| Type of response . | Phase 2 overall (N = 80) . | |
|---|---|---|
| n (%) . | 95% CI . | |
| CR | 17 (21) | 13-32 |
| PR | 0 | |
| mCR | 18 (22) | 14-33 |
| mCR with HI | 6 (7) | 3-16 |
| HI | 13 (16) | 9-26 |
| HI-E | 8 (10) | 4-19 |
| HI-N | 2 (2) | 0-9 |
| HI-P | 11 (14) | 7-23 |
| Overall response* (CR + PR + mCR + HI) | 48 (60) | 48-71 |
| No response | 32 (40) | 29-52 |
| Type of response . | Phase 2 overall (N = 80) . | |
|---|---|---|
| n (%) . | 95% CI . | |
| CR | 17 (21) | 13-32 |
| PR | 0 | |
| mCR | 18 (22) | 14-33 |
| mCR with HI | 6 (7) | 3-16 |
| HI | 13 (16) | 9-26 |
| HI-E | 8 (10) | 4-19 |
| HI-N | 2 (2) | 0-9 |
| HI-P | 11 (14) | 7-23 |
| Overall response* (CR + PR + mCR + HI) | 48 (60) | 48-71 |
| No response | 32 (40) | 29-52 |
CR, complete response; HI, hematologic improvement; HI-E, erythroid response; HI-N, neutrophil response; HI-P, platelet response; mCR, marrow complete response; PR, partial response.
Patients are counted only once with their best response as per the table hierarchy.